Munich Startup
Mermaid Bio

Mermaid Bio

Today’s antibody drugs reach only 10% of their potential targets, leaving many patients without treatment options. Mermaid Bio is pioneering the development of intrabody therapies to give patients new hope. Using cutting-edge biot...

Founded2022
Business ModelB2B
IndustryBioTech
This content was machine translated.

About Mermaid Bio

Today’s antibody drugs reach only 10% of their potential targets, leaving many patients without treatment options. Mermaid Bio is pioneering the development of intrabody therapies to give patients new hope. Using cutting-edge biotechnology, the company develops antibodies for intracellular targets (intrabodies) and treats diseases from within. Mermaid Bio is developing the next generation of antibody drugs to treat currently untreated patients in the future.

More like this

Discover more articles, startups, and events from the ecosystem

NextGen Takeover: How We Are Setting the Course for Tomorrow’s Entrepreneurs
Ecosystem

NextGen Takeover: How We Are Setting the Course for Tomorrow’s Entrepreneurs

06.08.26
4 Min.
Upcoming Startups in July
Inside Stories

Upcoming Startups in July

06.08.26
3 Min.
Munich Startup 2.0: From Showcase to Orientation Platform
Ecosystem

Munich Startup 2.0: From Showcase to Orientation Platform

05.08.26
4 Min.